ZNF674 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.218200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.246400E-01
Normal-vs-Stage2
3.884800E-01
Normal-vs-Stage3
1.060200E-02
Normal-vs-Stage4
9.731400E-01
Stage1-vs-Stage2
8.873800E-02
Stage1-vs-Stage3
9.157700E-03
Stage1-vs-Stage4
7.106200E-01
Stage2-vs-Stage3
8.233900E-02
Stage2-vs-Stage4
3.470200E-01
Stage3-vs-Stage4
4.626100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.617000E-01
Normal-vs-AfricanAmerican
5.138200E-01
Normal-vs-Asian
2.644400E-01
Caucasian-vs-AfricanAmerican
1.549410E-01
Caucasian-vs-Asian
4.662200E-01
AfricanAmerican-vs-Asian
4.492000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.205800E-01
Normal-vs-Female
5.611600E-01
Male-vs-Female
1.732230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.430800E-01
Normal-vs-Age(41-60Yrs)
6.824800E-01
Normal-vs-Age(61-80Yrs)
3.537400E-01
Normal-vs-Age(81-100Yrs)
7.760500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.182000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.079410E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.687900E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.838400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.856900E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.104000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.408200E-02
Normal-vs-Daily Drinker
2.014200E-01
Normal-vs-Weekly Drinker
3.422000E-01
Normal-vs-Occasional Drinker
4.443800E-01
Normal-vs-Social Drinker
7.189200E-01
Non Drinker-vs-Daily Drinker
6.404800E-01
Non Drinker-vs-Weekly Drinker
1.909760E-01
Non Drinker-vs-Occasional Drinker
9.577700E-02
Non Drinker-vs-Social Drinker
8.393600E-02
Daily Drinker-vs-Weekly Drinker
4.977000E-01
Daily Drinker-vs-Occasional Drinker
3.310600E-01
Daily Drinker-vs-Social Drinker
1.686600E-01
Weekly Drinker-vs-Occasional Drinker
8.071400E-01
Weekly Drinker-vs-Social Drinker
4.850600E-01
Occasional Drinker-vs-Social Drinker
6.057800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.567000E-01
Normal-vs-Grade 2
1.666820E-01
Normal-vs-Grade 3
1.906630E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.976600E-01
Grade 1-vs-Grade 3
4.134800E-01
Grade 1-vs-Grade 4
2.567000E-01
Grade 2-vs-Grade 3
5.472600E-01
Grade 2-vs-Grade 4
1.666820E-01
Grade 3-vs-Grade 4
1.906630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.147990E-01
Normal-vs-NonDiabetic
4.077000E-01
Diabetic-vs-NonDiabetic
1.190570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.161600E-01
Normal-vs-NoPancreatitis
3.458600E-01
Pancreatitis-vs-NoPancreatitis
9.666800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.691800E-01
Normal-vs-N1
3.364600E-01
N0-vs-N1
6.564400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.493400E-01
Normal-vs-TP53-NonMutant
7.082200E-01
TP53-Mutant-vs-TP53-NonMutant
1.482780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
